Literature DB >> 262804

An affinity method for the rapid purification of opsonic alpha 2 SB glycoprotein from serum.

F A Blumenstock, T M Saba, P Weber.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 262804

Source DB:  PubMed          Journal:  Adv Shock Res        ISSN: 0195-878X


× No keyword cloud information.
  8 in total

1.  Interactions of fibronectin with Treponema pallidum.

Authors:  T J Fitzgerald; L A Repesh
Journal:  Genitourin Med       Date:  1985-06

2.  Opsonic glycoprotein (plasma fibronectin) levels after burn injury. Relationship to extent of burn and development of sepsis.

Authors:  M E Lanser; T M Saba; W A Scovill
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

3.  Mechanism of acute depletion of plasma fibronectin following thermal injury in rats. Appearance of a gelatinlike ligand in plasma.

Authors:  D C Deno; M H McCafferty; T M Saba; F A Blumenstock
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

4.  Lung vascular permeability after reversal of fibronectin deficiency in septic sheep. Correlation with patient studies.

Authors:  T M Saba; G D Niehaus; W A Scovill; F A Blumenstock; J C Newell; J Holman; S R Powers
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

5.  Reversal of fibronectin and opsonic deficiency in patients. A controlled study.

Authors:  T M Saba; F A Blumenstock; D M Shah; J E Kaplan; E Cho; W Scovill; H Stratton; J Newell; M Gottlieb; N Sedransk
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

6.  [Fibronectin].

Authors:  E Klar; D L Heene
Journal:  Klin Wochenschr       Date:  1984-10-15

7.  Fibronectin levels during intraperitoneal inflammation.

Authors:  P S Richards; T M Saba
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

8.  Respiratory burst activity is impaired during phagocytosis of gelatinized fixed erythrocytes by inflammatory macrophages.

Authors:  P W Gudewicz; F A Blumenstock
Journal:  Inflammation       Date:  1987-12       Impact factor: 4.092

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.